Haemonetics (HAE) Tops Q2 EPS by 15c
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $75.07 +0.29%
Revenue Growth %: +2.3%
Financial Fact:
Cost of goods sold: 116.01M
Today's EPS Names:
CRMT, More
Revenue Growth %: +2.3%
Financial Fact:
Cost of goods sold: 116.01M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q2 EPS of $0.83, $0.15 better than the analyst estimate of $0.68. Revenue for the quarter came in at $297.48 million versus the consensus estimate of $270.46 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Pembina joins proposed 1M bbl/day Alberta-to-coast pipeline plan
- Waste stocks ride AI and healthcare boom as CLH surges 27%
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
